Health Condition 1: J45- Asthma
Conditions
Interventions
Intervention1: Oral Probiotics: Oral formulation (syrup) of probiotic containing the combination of Lactobacillus paracasei
and Lactobacillus fermentum (4 billion/2.5 mL once daily in early morning in
Sponsors
VEER SURENDRA SAI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH
Eligibility
Inclusion criteria
Inclusion criteria: Children in the age group of 7-14 years of either sex presenting to the Paediatrics department with diagnosis of asthma based on GINA definition.
Exclusion criteria
Exclusion criteria: 1. Critically ill or sick children. 2. Suspected or known immunodeficiency diseases. 3. Cardiac and neurological comorbidities. 4. Chronic pulmonary disease affecting pulmonary function. 5. Children who are not able to perform peak expiratory flow test optimally. 6. Children receiving probiotic for more than 1 month prior to study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Peak Expiratory Flow Rate (PEFR) (Liter/min) 2. Paediatric Asthma Quality of Life Questionnaire (PAQLQ)Timepoint: PEFR and PAQLQ score will be measured at the initiation of therapy (0 month), after 1 month and 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Prakash Chandra Panda
Veer Surendra Sai Institute of Medical Sciences & Research, Burla
Outcome results
None listed